PBRM1 loss tended to increase with rising tumor stage, i.e., 25% (13%) for stage I, 30% (16%) for stage II, 18% (9%) for stage III, and 50% (29%) for stage IV (Fig 3B). The gene discussed is PBRM1; the disease is neoplasm.